lomustine

lomustine is often used in combination with other chemotherapeutic agents.

the lomustine dosage must be carefully calculated based on patient weight.

lomustine therapy requires regular monitoring of blood cell counts.

patients receiving lomustine may experience delayed myelosuppression.

lomustine has shown efficacy in treating certain brain tumors.

the lomustine treatment protocol involves oral administration.

lomustine can cause pulmonary toxicity as a serious side effect.

dose adjustment may be necessary for patients with liver dysfunction.

resistance to lomustine can develop during prolonged treatment.

lomustine crosses the blood-brain barrier effectively.

the combination of lomustine and procarbazine is used for gliomas.

long-term follow-up is essential for lomustine patients.